These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 32283250)

  • 21. Retrospective monitoring of perfluorocarboxylates and perfluorosulfonates in human plasma archived by the German Environmental Specimen Bank.
    Schröter-Kermani C; Müller J; Jürling H; Conrad A; Schulte C
    Int J Hyg Environ Health; 2013 Nov; 216(6):633-40. PubMed ID: 22999890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of pregnancy on the levels of selected perfluoroalkyl compounds for females aged 17-39 years: data from National Health and Nutrition Examination Survey 2003-2008.
    Jain RB
    J Toxicol Environ Health A; 2013; 76(7):409-21. PubMed ID: 23611181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between perfluoroalkyl substances and serum lipids in a Swedish adult population with contaminated drinking water.
    Li Y; Barregard L; Xu Y; Scott K; Pineda D; Lindh CH; Jakobsson K; Fletcher T
    Environ Health; 2020 Mar; 19(1):33. PubMed ID: 32169067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma Perfluoroalkyl and Polyfluoroalkyl Substances Concentration and Menstrual Cycle Characteristics in Preconception Women.
    Zhou W; Zhang L; Tong C; Fang F; Zhao S; Tian Y; Tao Y; Zhang J;
    Environ Health Perspect; 2017 Jun; 125(6):067012. PubMed ID: 28657892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Association Between Perfluoroalkyl Substances and Lipids in Cord Blood.
    Spratlen MJ; Perera FP; Lederman SA; Robinson M; Kannan K; Herbstman J; Trasande L
    J Clin Endocrinol Metab; 2020 Jan; 105(1):43-54. PubMed ID: 31536623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between prenatal exposure to perfluoroalkyl substances and anogenital distance in female neonates.
    Li J; Yang L; He G; Wang B; Miao M; Ji H; Wen S; Cao W; Yuan W; Liang H
    Ecotoxicol Environ Saf; 2022 Oct; 245():114130. PubMed ID: 36182800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal trends of perfluoroalkyl acids in plasma samples of pregnant women in Hokkaido, Japan, 2003-2011.
    Okada E; Kashino I; Matsuura H; Sasaki S; Miyashita C; Yamamoto J; Ikeno T; Ito YM; Matsumura T; Tamakoshi A; Kishi R
    Environ Int; 2013 Oct; 60():89-96. PubMed ID: 24013022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perfluoroalkyl substances and time to pregnancy in couples from Greenland, Poland and Ukraine.
    Jørgensen KT; Specht IO; Lenters V; Bach CC; Rylander L; Jönsson BA; Lindh CH; Giwercman A; Heederik D; Toft G; Bonde JP
    Environ Health; 2014 Dec; 13():116. PubMed ID: 25533644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exposure to Perfluoroalkyl Substances and Metabolic Outcomes in Pregnant Women: Evidence from the Spanish INMA Birth Cohorts.
    Matilla-Santander N; Valvi D; Lopez-Espinosa MJ; Manzano-Salgado CB; Ballester F; Ibarluzea J; Santa-Marina L; Schettgen T; Guxens M; Sunyer J; Vrijheid M
    Environ Health Perspect; 2017 Nov; 125(11):117004. PubMed ID: 29135438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of prenatal exposure to perfluoroalkyl substances in the Slovak birth cohort.
    Richterová D; Fábelová L; Patayová H; Pulkrabová J; Lanková D; Rausová K; Šovčíková E; Štencl J; Hajšlová J; Trnovec T; Palkovičová Murínová Ľ
    Environ Int; 2018 Dec; 121(Pt 2):1304-1310. PubMed ID: 30420127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Per- and polyfluoroalkyl substance (PFAS) exposure assessment in a community exposed to contaminated drinking water, New Hampshire, 2015.
    Daly ER; Chan BP; Talbot EA; Nassif J; Bean C; Cavallo SJ; Metcalf E; Simone K; Woolf AD
    Int J Hyg Environ Health; 2018 Apr; 221(3):569-577. PubMed ID: 29514764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested case-control study in the Danish National Birth Cohort.
    Liew Z; Ritz B; von Ehrenstein OS; Bech BH; Nohr EA; Fei C; Bossi R; Henriksen TB; Bonefeld-Jørgensen EC; Olsen J
    Environ Health Perspect; 2015 Apr; 123(4):367-73. PubMed ID: 25616253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perfluoroalkyl acids in pregnant women from Nunavik (Quebec, Canada): Trends in exposure and associations with country foods consumption.
    Caron-Beaudoin É; Ayotte P; Blanchette C; Muckle G; Avard E; Ricard S; Lemire M
    Environ Int; 2020 Dec; 145():106169. PubMed ID: 33041046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010.
    Khalil N; Chen A; Lee M; Czerwinski SA; Ebert JR; DeWitt JC; Kannan K
    Environ Health Perspect; 2016 Jan; 124(1):81-7. PubMed ID: 26058082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prenatal Exposure to Perfluoroalkyl Acids and Serum Testosterone Concentrations at 15 Years of Age in Female ALSPAC Study Participants.
    Maisonet M; Calafat AM; Marcus M; Jaakkola JJ; Lashen H
    Environ Health Perspect; 2015 Dec; 123(12):1325-30. PubMed ID: 26034840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal exposure to perfluoroalkyl substances and adipocytokines: the HOME Study.
    Buck CO; Eliot MN; Kelsey KT; Calafat AM; Chen A; Ehrlich S; Lanphear BP; Braun JM
    Pediatr Res; 2018 Dec; 84(6):854-860. PubMed ID: 30250302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal exposure to perfluorinated acids and fetal growth.
    Hamm MP; Cherry NM; Chan E; Martin JW; Burstyn I
    J Expo Sci Environ Epidemiol; 2010 Nov; 20(7):589-97. PubMed ID: 19865074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women.
    Brantsæter AL; Whitworth KW; Ydersbond TA; Haug LS; Haugen M; Knutsen HK; Thomsen C; Meltzer HM; Becher G; Sabaredzovic A; Hoppin JA; Eggesbø M; Longnecker MP
    Environ Int; 2013 Apr; 54():74-84. PubMed ID: 23419425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variability of perfluoroalkyl substance concentrations in pregnant women by socio-demographic and dietary factors in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Martinez D; Ibarluzea J; Santa-Marina L; Schettgen T; Vioque J; Sunyer J; Vrijheid M
    Environ Int; 2016; 92-93():357-65. PubMed ID: 27132161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.